Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

Do Targeted Therapies Drive Disparities?

MELISSA B. DAVIS, PHD
Sunday, April 28, 2019


After the implementation of targeted therapies, researchers saw a larger gap in breast cancer mortality rates between African American and Caucasian women, according to Melissa B. Davis, PhD, an assistant professor at Weill Cornell Medicine. 

Targeted therapies caused a decline in deaths in white women, while deaths in black women essentially stayed the same. Some of this can be attributed to access to healthcare, but upon further investigation, researchers also found that the 2 groups have differences in their tumor biology and types of breast cancer, thus making these new treatments more efficacious in the Caucasian population.
 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.